Next Article in Journal
Cross-Linked Dependency of Boronic Acid-Conjugated Chitosan Nanoparticles by Diols for Sustained Insulin Release
Next Article in Special Issue
Evaluation of Extrusion Technique for Nanosizing Liposomes
Previous Article in Journal
An Accelerated Release Study to Evaluate Long-Acting Contraceptive Levonorgestrel-Containing in Situ Forming Depot Systems
Previous Article in Special Issue
Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes

Rapid Quantification and Validation of Lipid Concentrations within Liposomes

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK
Aston Pharmacy School, School of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK
School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine BT52 1SA, UK
Author to whom correspondence should be addressed.
Academic Editor: Natasa Skalko-Basnet
Pharmaceutics 2016, 8(3), 29;
Received: 14 July 2016 / Revised: 18 August 2016 / Accepted: 2 September 2016 / Published: 13 September 2016
(This article belongs to the Special Issue Liposome Technologies 2015)
Quantification of the lipid content in liposomal adjuvants for subunit vaccine formulation is of extreme importance, since this concentration impacts both efficacy and stability. In this paper, we outline a high performance liquid chromatography-evaporative light scattering detector (HPLC-ELSD) method that allows for the rapid and simultaneous quantification of lipid concentrations within liposomal systems prepared by three liposomal manufacturing techniques (lipid film hydration, high shear mixing, and microfluidics). The ELSD system was used to quantify four lipids: 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), cholesterol, dimethyldioctadecylammonium (DDA) bromide, and ᴅ-(+)-trehalose 6,6′-dibehenate (TDB). The developed method offers rapidity, high sensitivity, direct linearity, and a good consistency on the responses (R2 > 0.993 for the four lipids tested). The corresponding limit of detection (LOD) and limit of quantification (LOQ) were 0.11 and 0.36 mg/mL (DMPC), 0.02 and 0.80 mg/mL (cholesterol), 0.06 and 0.20 mg/mL (DDA), and 0.05 and 0.16 mg/mL (TDB), respectively. HPLC-ELSD was shown to be a rapid and effective method for the quantification of lipids within liposome formulations without the need for lipid extraction processes. View Full-Text
Keywords: lipids; liposomes; cholesterol; quantification; HPLC; ELSD lipids; liposomes; cholesterol; quantification; HPLC; ELSD
Show Figures

Graphical abstract

MDPI and ACS Style

Roces, C.B.; Kastner, E.; Stone, P.; Lowry, D.; Perrie, Y. Rapid Quantification and Validation of Lipid Concentrations within Liposomes. Pharmaceutics 2016, 8, 29.

AMA Style

Roces CB, Kastner E, Stone P, Lowry D, Perrie Y. Rapid Quantification and Validation of Lipid Concentrations within Liposomes. Pharmaceutics. 2016; 8(3):29.

Chicago/Turabian Style

Roces, Carla B., Elisabeth Kastner, Peter Stone, Deborah Lowry, and Yvonne Perrie. 2016. "Rapid Quantification and Validation of Lipid Concentrations within Liposomes" Pharmaceutics 8, no. 3: 29.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop